Fungal Diversity in Gut Microbiota in Patients with Cancer

kamal ahmad khidir, Ibrahim Hamad, Hiwa A. Ahmad

Abstract


 

        Patients who have cancer are more prone to get infections than healthy individuals. In this study, we applied cloning sequencing technique to identify the mycobiome and other transient fungal components in the digestive tract of patients with acute myeloid leukemia (AML), non- Hodgkin’s lymphoma (NHL), Leucopenia and anemia and compare it with the fungal components of healthy individuals. Fungal universal primer pair targeting ITS region of the fungal genome was used to assess the fungal components in fecal samples. Approximately more than 1,481 clones were selected and subjected to sequence analysis resulted in detection of a total of 44 and 43 fungal species from both fecal samples of cancer patients and healthy control individuals respectively. The majority of fungi were assigned to the 3 taxa Ascomycota (n = 39/63, 61.9 %), Basidiomycota (n = 23/63, 36.5 %) and Zygomycota (n= 1/63, 1.6 %). Fungal species such as Candida parapsilosis, Candida dubliniensis, Malassezia restricta were represented only in the feces of cancer patients. Moreover, the results from analyzing ITS clone library revealed that the most frequently detected fungi of the Malassezia genus (Malassezia globosa, Malassezia pachydermatis, Malassezia restricta) were retrieved in high amount in the fecal samples of cancer patients compared with those of healthy volunteers. Further efforts and studies are needed to shed light on the complex relationships between the fungal populations and the host immune system in cancer patients.


Keywords


: Fungal ITS, Cloning, Detection, Metagenomics, sequencing, Taxonomy

Full Text:

PDF

References


REFERENCES

ALPERT, G., BELL, L. M. & CAMPOS, J. M. 1987. Malassezia furfur fungemia in infancy. Clinical pediatrics, 26, 528-531.

ANAISSIE, E., BODEY, G. P., KANTARJIAN, H., RO, J., VARTIVARIAN, S. E., HOPFER, R., HOY, J. & ROLSTON, K. 1989. New spectrum of fungal infections in patients with cancer. Reviews of infectious diseases, 11, 369-378.

ASCIOGLU, S., REX, J., DE PAUW, B., BENNETT, J., BILLE, J., CROKAERT, F., DENNING, D., DONNELLY, J., EDWARDS, J. & ERJAVEC, Z. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical infectious diseases, 34, 7-14.

ASHBEE, H. 2007. Update on the genus Malassezia. Medical Mycology, 45, 287-303.

BARBER, G. R., BROWN, A. E., KIEHN, T. E., EDWARDS, F. F. & ARMSTRONG, D. 1993. Catheter-related Malassezia furfur fungemia in immunocompromised patients. The American journal of medicine, 95, 365-370.

CASSONE, M., SERRA, P., MONDELLO, F., GIROLAMO, A., SCAFETTI, S., PISTELLA, E. & VENDITTI, M. 2003. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Journal of clinical microbiology, 41, 5340-5343.

CHEN, Y., EISNER, J., KATTAR, M., RASSOULIAN-BARRETT, S., LAFE, K., YARFITZ, S., LIMAYE, A. & COOKSON, B. 2000. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. Journal of clinical microbiology, 38, 2302-2310.

CUI, L., MORRIS, A. & GHEDIN, E. 2013. The human mycobiome in health and disease. Genome medicine, 5, 63.

DANAI, P. A., MOSS, M., MANNINO, D. M. & MARTIN, G. S. 2006. The epidemiology of sepsis in patients with malignancy. Chest, 129, 1432-1440.

DE OLIVEIRA, R. B., ATOBE, J. H., SOUZA, S. A. & SANTOS, D. W. D. C. L. 2014. Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil. Mycopathologia, 178, 71-78.

FRANZEN, C. & MÜLLER, A. 1999. Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clinical Microbiology Reviews, 12, 243-285.

FREYDIERE, A.-M., GUINET, R. & BOIRON, P. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Sabouraudia, 39, 9-33.

GIDDING, H., HAWES, L. & DWYER, B. 1989. The isolation of Malassezia furfur from an episode of peritonitis. The Medical Journal of Australia, 151, 603-603.

GOUBA, N. & DRANCOURT, M. 2015. Digestive tract mycobiota: a source of infection. Medecine et maladies infectieuses, 45, 9-16.

GUPTA, A. K., BATRA, R., BLUHM, R., BOEKHOUT, T. & DAWSON, T. L. 2004. Skin diseases associated with Malassezia species. Journal of the American Academy of Dermatology, 51, 785-798.

HAMAD, I., SOKHNA, C., RAOULT, D. & BITTAR, F. 2012. Molecular detection of eukaryotes in a single human stool sample from Senegal. PloS one, 7, e40888.

KONTOYIANNIS, D. & BODEY, G. 2002. Invasive aspergillosis in 2002: an update. European journal of clinical microbiology & infectious diseases, 21, 161-172.

LATUGA, M. S., ELLIS, J. C., COTTON, C. M., GOLDBERG, R. N., WYNN, J. L., JACKSON, R. B. & SEED, P. C. 2011. Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants. PloS one, 6, e27858.

LECCIONES, J. A., LEE, J. W., NAVARRO, E. E., WITEBSKY, F. G., MARSHALL, D., STEINBERG, S. M., PIZZO, P. A. & WALSH, T. J. 1992. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clinical infectious diseases, 14, 875-883.

MARTIN, G. S., MANNINO, D. M., EATON, S. & MOSS, M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine, 348, 1546-1554.

NUCCI, M. & ANAISSIE, E. 2001. Revisiting the source of candidemia: skin or gut? Clinical infectious diseases, 33, 1959-1967.

OBERLE, A. D., FOWLER, M. & GRAFTON, W. D. 1981. Pityrosporum isolate from the upper respiratory tract. American journal of clinical pathology, 76, 112-116.

OTT, S. J., KÜHBACHER, T., MUSFELDT, M., ROSENSTIEL, P., HELLMIG, S., REHMAN, A., DREWS, O., WEICHERT, W., TIMMIS, K. N. & SCHREIBER, S. 2008. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scandinavian journal of gastroenterology, 43, 831-841.

PFALLER, M. & DIEKEMA, D. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews, 20, 133-163.

RAJILIĆ-STOJANOVIĆ, M. & DE VOS, W. M. 2014. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS microbiology reviews, 38, 996-1047.

SAFDAR, A. & ARMSTRONG, D. 2001. Infectious morbidity in critically ill patients with cancer. Critical care clinics, 17, 531-570.

SAVAGE, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annual Reviews in Microbiology, 31, 107-133.

SCANLAN, P. D. & MARCHESI, J. R. 2008. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and-independent analysis of faeces. The ISME journal, 2, 1183.

SETHI, S., SEHGAL, R., MALLA, N. & MAHAJAN, R. 1998. Cryptosporidiosis in a tertiary care hospital. The National medical journal of India, 12, 207-209.

SUAU, A., BONNET, R., SUTREN, M., GODON, J.-J., GIBSON, G. R., COLLINS, M. D. & DORÉ, J. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Applied and environmental microbiology, 65, 4799-4807.

TRAGIANNIDIS, A., BISPING, G., KOEHLER, G. & GROLL, A. H. 2010. Minireview: Malassezia infections in immunocompromised patients. Mycoses, 53, 187-195.

TURENNE, C. Y., SANCHE, S. E., HOBAN, D. J., KARLOWSKY, J. A. & KABANI, A. M. 1999. Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system. Journal of clinical microbiology, 37, 1846-1851.

VELEGRAKI, A., CAFARCHIA, C., GAITANIS, G., IATTA, R. & BOEKHOUT, T. 2015. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS pathogens, 11, e1004523.

VISCOLI, C., GIRMENIA, C., MARINUS, A., COLLETTE, L., MARTINO, P., VANDERCAM, B., DOYEN, C., LEBEAU, B., SPENCE, D. & KRCMERY, V. 1999. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clinical infectious diseases, 28, 1071-1079.

WALSH, T., GROLL, A., HIEMENZ, J., FLEMING, R., ROILIDES, E. & ANAISSIE, E. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clinical Microbiology and Infection, 10, 48-66.

WILLIAMS, M. D., BRAUN, L. A., COOPER, L. M., JOHNSTON, J., WEISS, R. V., QUALY, R. L. & LINDE-ZWIRBLE, W. 2004. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Critical Care, 8, R291.




Copyright (c) 2017 ZANCO Journal of Pure and Applied Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

ZANCO Journal of Pure and Applied Sciences (print version: ISSN 2218-0230 online version: ISSN 2412-3986, DOI: 10.21271) is published by Salahaddin University-Erbil / Department of Scientific Publications. Responsibility for the contents rests upon the authors and not upon  Salahaddin University-Erbil or the Journal Editorial and Advisory Boards. 

Department of Scientific Publication Office: The Central Library of Salahaddin University-Erbil, Kirkuk Road, Erbil, Kurdistan, Iraq. Cell Phone: +964 (0)750 7761675, email: zanco.scientific@su.edu.krd. www.su.edu.krd, www.zancojournals.su.edu.krd

Copyright and Reprint Permission: It is the policy of ZANCO to own the copyright to the technical contributions it publishes and to facilitate the appropriate reuse of this material by others. Photocopying is permitted with credit to the source for individuals for individual use.

Copyright © 2017. All Rights Reserved. Salahaddin University-Erbil